Literature DB >> 8618276

Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery.

S E Lerner1, C A Hawkins, M L Blute, A Grabner, P C Wollan, J T Eickholt, H Zincke.   

Abstract

PURPOSE: We investigated the outcome of nephron sparing surgery in patients with low grade and low stage (Robson stage II or less) renal cell carcinoma.
MATERIALS AND METHODS: We retrospectively reviewed the records of 185 patients treated with nephron sparing surgery and 209 matched for patient age and sex, and tumor stage and grade who were treated with radical nephrectomy. Kaplan-Meier survival curves were constructed for progression and survival end points. Multivariate analysis was performed to determine the tumor characteristics independently correlated with progression and cancer death.
RESULTS: No significant difference was observed with respect to progression-free, crude or cancer specific survival between the nephron sparing surgery and radical nephrectomy groups. Less than 5% of the patients treated with conservative nephron sparing surgery had local recurrence. Tumor size was a strong independent predictor of outcome, whereas Robson stage was not. Patients treated with radical nephrectomy had a significant cancer specific and progression-free survival advantage when controlling for tumor diameter and grade. However, no difference was observed in patients with primary tumor diameters of 4 cm. or less.
CONCLUSIONS: Robson staging is inaccurate in predicting tumor behavior. Patients with tumors larger than 4 cm. and a normal contralateral kidney may be best served by radical nephrectomy rather than elective nephron sparing surgery. However, nephron sparing surgery may result in an outcome similar to that of radical nephrectomy for low grade, low stage renal cell carcinomas of 4 cm. or smaller.

Entities:  

Mesh:

Year:  1996        PMID: 8618276

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  49 in total

Review 1.  Should there be a size limit for elective nephron-sparing surgery?

Authors:  Kent G Krejci; Bradley C Leibovich
Journal:  Curr Urol Rep       Date:  2003-02       Impact factor: 3.092

2.  Maximum tensile force of different suture techniques in reconstruction of the renal remnant after nephron-sparing surgery.

Authors:  J Simon; F Finter; A Ignatius; M Meilinger; L Dürselen
Journal:  Surg Endosc       Date:  2010-07-07       Impact factor: 4.584

3.  Best of the 2002 AUA Annual Meeting: Highlights of the 2002 Annual Meeting of the American Urological Association May 25-30, 2002, Orlando, FL.

Authors: 
Journal:  Rev Urol       Date:  2002

Review 4.  The role of minimally invasive surgery in multifocal renal cell carcinoma.

Authors:  Serge Ginzburg; Robert G Uzzo; Alexander Kutikov
Journal:  Curr Urol Rep       Date:  2012-06       Impact factor: 3.092

5.  The case for radical nephrectomy.

Authors:  Mark Louie-Johnsun; Andre Lalak
Journal:  Ann R Coll Surg Engl       Date:  2008-05       Impact factor: 1.891

6.  Complications after radical and partial nephrectomy as a function of age.

Authors:  William T Lowrance; David S Yee; Caroline Savage; Angel M Cronin; Matthew F O'Brien; S Machele Donat; Andrew Vickers; Paul Russo
Journal:  J Urol       Date:  2010-03-17       Impact factor: 7.450

7.  Radiofrequency ablation versus nephron-sparing surgery for small unilateral renal cell carcinoma: cost-effectiveness analysis.

Authors:  Pari V Pandharipande; Debra A Gervais; Peter R Mueller; Chin Hur; G Scott Gazelle
Journal:  Radiology       Date:  2008-05-05       Impact factor: 11.105

8.  Role of open nephron sparing surgery in the era of minimal invasive surgery.

Authors:  Gaurav Gupta; Sameer Grover; Santosh Kumar; Nitin S Kekre
Journal:  Indian J Urol       Date:  2009 Oct-Dec

9.  Molecular targeted therapy in advanced renal cell carcinoma: A review of its recent past and a glimpse into the near future.

Authors:  John S P Yuen
Journal:  Indian J Urol       Date:  2009 Oct-Dec

10.  Staging of renal cell carcinoma: Current concepts.

Authors:  John S Lam; Tobias Klatte; Alberto Breda
Journal:  Indian J Urol       Date:  2009 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.